Titrimetric determination of Cremophor® EL in aqueous solutions and biofluids

This publication has 18 references indexed in Scilit:

• Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of Paclitaxel
  JNCI Journal of the National Cancer Institute, 1996
• Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1996
• Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant Phenotype
  JNCI Journal of the National Cancer Institute, 1993
• An in Vitro Model of Cyclosporine-Induced Nephrotoxicity
  Fundamental and Applied Toxicology, 1993
• Short-Term Effect of Various Doses of Cyclosporin A on Plasma Lipoproteins and its Distribution in Blood: An Experimental Study
  Human & Experimental Toxicology, 1993
• THE HEMODYNAMIC EFFECTS OF CREMOPHOR-EL
  Transplantation, 1991
• Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C
  Biochemical and Biophysical Research Communications, 1989
• Titrations of bivalent metal ions with sodium tetraphenylborate in the presence of polyethylene glycol
  The Analyst, 1988
• Suspected anaphylactic reaction to Cremophor EL.
  BMJ, 1980
• Grenzflächenreaktionen zwischen kolloider Kieselsäure und Polyäthylenglykol sowie Polyäthylenglykolderivaten
  Colloid and Polymer Science, 1970